Traumatic Brain Injury (TBI) Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | SanBio, Vasopharm GmbH, Pinteon Therapeutics, NeuroTrauma Sciences

Traumatic Brain Injury (TBI) Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | SanBio, Vasopharm GmbH, Pinteon Therapeutics, NeuroTrauma Sciences
Delveinsight Business Research LLP
As per DelveInsight, the Traumatic Brain Injury Market is anticipated to evolve immensely in the coming years owing to the increasing incidence of TBI, improved diagnosis, and the anticipated launch of novel therapies in the market.

DelveInsight’s “Traumatic Brain Injury Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Traumatic Brain Injury market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The report covers emerging Traumatic Brain Injury drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Traumatic Brain Injury treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Traumatic Brain Injury Market

Traumatic Brain Injury: An Overview

According to the American Association of Neurological Surgeons (2022), Traumatic Brain Injury (TBI) is a disruption in the normal function of the brain that can be caused by a blow, bump, or jolt to the head, the head suddenly and violently hitting an object or when an object pierces the skull and enters brain tissue. 

A computed tomography scan (CT or CAT scan) is the gold standard for the radiological assessment of a TBI patient. A CT scan is easy to perform and an excellent test for detecting the presence of blood and fractures, the most crucial lesions to identify in medical trauma cases. Plain X-rays of the skull are recommended by some as a way to evaluate patients with only mild neurological dysfunction. However, most centers in the US have readily available CT scanning, a more accurate test, rendering the routine use of skull X-rays for TBI patients to decline.

Traumatic Brain Injury Market Key Facts

  • According to Galgano et al. (2017), the highest rates of TBI tend to be in a very young age group (0–4 y) as well as in adolescents and young adults (15–24 y). There is another peak in incidence in the elderly (>65 y).

  • According to the CDC, approximately 2.87 million cases of TBI occurred in the US in 2014 with over 837,000 cases occurring amongst children. An estimated 13.5 million individuals live with a disability due to traumatic brain injury in the US alone.

  • A few major market players in the Traumatic Brain Injury market include VAS203 (Ronopterin) (Vasopharm GmbH), and PNT001 (Pinteon Therapeutics ), amongst others.

Traumatic Brain Injury Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Traumatic Brain Injury pipeline therapies. It also thoroughly assesses the Traumatic Brain Injury market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.

The report gives complete detail of the market trend for each marketed Traumatic Brain Injury drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.

Traumatic Brain Injury Epidemiology Assessment 

The epidemiology section provides insights into the historical, current, and forecasted Traumatic Brain Injury epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted Traumatic Brain Injury epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pools, future trends, and views of key opinion leaders. 

The Report Covers the Traumatic Brain Injury Epidemiology, Segmented as –

  • Total Incident Cases of Traumatic Brain Injury (TBI) [2019–2032]

  • Incident Cases of Traumatic Brain Injury (TBI) by Age Group [2019–2032]

  • Severity-specific Cases of Traumatic Brain Injury (TBI) [2019–2032]

  • Gender-specific Cases of Traumatic Brain Injury (TBI) [2019–2032]

Traumatic Brain Injury Drugs Uptake and Pipeline Development Activities

The drug uptake section focuses on the uptake rate of potential drugs recently launched in the Traumatic Brain Injury market or expected to be launched during the study period. The analysis covers the Traumatic Brain Injury market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the market dynamics by drug sales, the most rapid drug uptake, and the reasons behind the maximal use of particular drugs. Additionally, it compares Traumatic Brain Injury drugs based on their sale and market share.

The report also covers the Traumatic Brain Injury pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key Traumatic Brain Injury companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Learn How the Traumatic Brain Injury Market Will Evolve and Grow by 2032 @

Traumatic Brain Injury Therapeutics Analysis

There are no approved disease-specific treatments for TBI patients, although several new molecules are under investigation. Treatment with several agents like Anti-anxiety medication, Anticoagulants, Anticonvulsants, Antidepressants, Diuretics, Muscle relaxants, and Stimulants can help manage symptoms. 

Since the treatment landscape is devoid of any effective curative treatment options, any significant development in this direction is expected to create a tectonic impact on the existing market scenario. To counter unmet market needs and provide better treatment choices for TBI, several market players are working robustly either on single-agent novel molecules or on combination and dose modification of standard therapies. Several therapies are expected to be launched in the upcoming years. 

Traumatic Brain Injury Companies Actively Working in the Therapeutics Market Include

  • Vasopharm GmbH

  • Pinteon Therapeutics

  • NeuroTrauma Sciences

  • SanBio

And Many Others

Emerging and Marketed Traumatic Brain Injury Therapies Covered in the Report Include:

  • VAS203 (Ronopterin): Vasopharm GmbH

  • PNT001: Pinteon Therapeutics

  • NTS-105: NeuroTrauma Sciences

  • Vandefitemcel: SanBio

And Many More

The Report Covers the In-depth Assessment of the Emerging Drugs & Key Companies. Download the Sample Report to Learn More @

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Traumatic Brain Injury Competitive Intelligence Analysis

4. Traumatic Brain Injury Market Overview at a Glance

5. Traumatic Brain Injury Disease Background and Overview

6. Traumatic Brain Injury Patient Journey

7. Traumatic Brain Injury Patient Population and Epidemiology Trends (In the US, EU5, and Japan)

8. Traumatic Brain Injury Treatment Algorithm, Current Treatment, and Medical Practices

9. Traumatic Brain Injury Unmet Needs

10. Key Endpoints of Traumatic Brain Injury Treatment

11. Traumatic Brain Injury Marketed Therapies

12. Traumatic Brain Injury Emerging Drugs and Latest Therapeutic Advances

13. Traumatic Brain Injury Seven Major Market Analysis

14. Attribute Analysis

15. Traumatic Brain Injury Market Outlook (In US, EU5, and Japan)

16. Traumatic Brain Injury Companies Active in the Market

17. Traumatic Brain Injury Access and Reimbursement Overview

18. KOL Views on the Traumatic Brain Injury Market

19. Traumatic Brain Injury Market Drivers

20. Traumatic Brain Injury Market Barriers

21. Appendix

22. DelveInsight Capabilities

23. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download the Sample PDF to Learn More About the Key Offerings of the Report @


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.


Other Trending Healthcare Reports by DelveInsight 

Prosthetic Heart Valve Market

“Prosthetic Heart Valve  Market Insight, Competitive Landscape, and Market Forecast, 2028” report delivers an in-depth understanding of historical and forecasted Prosthetic Heart Valve market size, share, and trends globally, which comprises North America, Europe, APAC, and RoW. Moreover, it covers the key companies, emerging products, and commercial & regulatory development, in the Prosthetic Heart Valve Market.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States